vs

Side-by-side financial comparison of P3 Health Partners Inc. (PIII) and T1 Energy Inc. (TE). Click either name above to swap in a different company.

P3 Health Partners Inc. is the larger business by last-quarter revenue ($384.8M vs $210.5M, roughly 1.8× T1 Energy Inc.). P3 Health Partners Inc. runs the higher net margin — -19.6% vs -62.0%, a 42.4% gap on every dollar of revenue.

P3 Health Partners Inc. is a population health management and value-based care services firm operating primarily in the United States. It partners with primary care providers and health systems to deliver coordinated, high-quality care for patient populations, especially Medicare Advantage beneficiaries, focusing on improving health outcomes and lowering unnecessary healthcare costs.

Sony Energy Devices Corporation , is a Japanese multinational company specializing in a variety of areas in the energy industry, and is a wholly owned subsidiary and part of the Devices Group of Sony. The company was established in February 1975 in Fukushima, Japan.

PIII vs TE — Head-to-Head

Bigger by revenue
PIII
PIII
1.8× larger
PIII
$384.8M
$210.5M
TE
Higher net margin
PIII
PIII
42.4% more per $
PIII
-19.6%
-62.0%
TE

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
PIII
PIII
TE
TE
Revenue
$384.8M
$210.5M
Net Profit
$-75.5M
$-130.6M
Gross Margin
10.0%
Operating Margin
-40.0%
-45.0%
Net Margin
-19.6%
-62.0%
Revenue YoY
3.8%
Net Profit YoY
-28.8%
-375.2%
EPS (diluted)
$-23.08
$-0.87

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PIII
PIII
TE
TE
Q4 25
$384.8M
Q3 25
$345.3M
$210.5M
Q2 25
$355.8M
$132.8M
Q1 25
$373.2M
$53.5M
Q4 24
$370.7M
Q3 24
$362.1M
$0
Q2 24
$379.2M
$0
Q1 24
$388.5M
$0
Net Profit
PIII
PIII
TE
TE
Q4 25
$-75.5M
Q3 25
$-31.6M
$-130.6M
Q2 25
$-20.4M
$-31.9M
Q1 25
$-20.5M
$-16.2M
Q4 24
$-58.6M
Q3 24
$-46.5M
$-27.5M
Q2 24
$-12.0M
$-27.0M
Q1 24
$-18.7M
$-28.5M
Gross Margin
PIII
PIII
TE
TE
Q4 25
Q3 25
10.0%
Q2 25
24.7%
Q1 25
33.3%
Q4 24
Q3 24
Q2 24
Q1 24
Operating Margin
PIII
PIII
TE
TE
Q4 25
-40.0%
Q3 25
-12.8%
-45.0%
Q2 25
-9.6%
-22.0%
Q1 25
-10.2%
-44.2%
Q4 24
-37.4%
Q3 24
-29.5%
Q2 24
-8.3%
Q1 24
-11.3%
Net Margin
PIII
PIII
TE
TE
Q4 25
-19.6%
Q3 25
-9.1%
-62.0%
Q2 25
-5.7%
-24.0%
Q1 25
-5.5%
-30.4%
Q4 24
-15.8%
Q3 24
-12.8%
Q2 24
-3.2%
Q1 24
-4.8%
EPS (diluted)
PIII
PIII
TE
TE
Q4 25
$-23.08
Q3 25
$-9.67
$-0.87
Q2 25
$-6.23
$-0.21
Q1 25
$-6.28
$-0.11
Q4 24
$-23.13
Q3 24
$-15.70
$-0.20
Q2 24
$-7.37
$-0.19
Q1 24
$-7.86
$-0.20

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PIII
PIII
TE
TE
Cash + ST InvestmentsLiquidity on hand
$25.0M
$34.1M
Total DebtLower is stronger
$228.4M
$547.3M
Stockholders' EquityBook value
$-155.2M
$96.9M
Total Assets
$656.6M
$1.4B
Debt / EquityLower = less leverage
5.65×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PIII
PIII
TE
TE
Q4 25
$25.0M
Q3 25
$37.7M
$34.1M
Q2 25
$38.6M
$8.5M
Q1 25
$40.1M
$48.9M
Q4 24
$38.8M
Q3 24
$63.0M
$181.9M
Q2 24
$73.1M
$219.6M
Q1 24
$27.3M
$249.9M
Total Debt
PIII
PIII
TE
TE
Q4 25
$228.4M
Q3 25
$252.8M
$547.3M
Q2 25
$182.0M
$591.2M
Q1 25
$171.1M
$603.2M
Q4 24
$108.9M
Q3 24
$133.2M
Q2 24
$133.1M
Q1 24
$118.1M
$602.3M
Stockholders' Equity
PIII
PIII
TE
TE
Q4 25
$-155.2M
Q3 25
$-18.7M
$96.9M
Q2 25
$44.5M
$183.9M
Q1 25
$63.3M
$201.9M
Q4 24
$75.9M
Q3 24
$120.5M
$538.7M
Q2 24
$166.8M
$561.6M
Q1 24
$146.6M
$582.3M
Total Assets
PIII
PIII
TE
TE
Q4 25
$656.6M
Q3 25
$683.6M
$1.4B
Q2 25
$731.6M
$1.4B
Q1 25
$783.9M
$1.4B
Q4 24
$783.4M
Q3 24
$833.3M
$615.0M
Q2 24
$892.8M
$644.4M
Q1 24
$855.9M
$670.3M
Debt / Equity
PIII
PIII
TE
TE
Q4 25
Q3 25
5.65×
Q2 25
4.09×
3.21×
Q1 25
2.71×
2.99×
Q4 24
1.43×
Q3 24
1.11×
Q2 24
0.80×
Q1 24
0.81×
1.03×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PIII
PIII
TE
TE
Operating Cash FlowLast quarter
$-25.7M
$63.9M
Free Cash FlowOCF − Capex
$55.0M
FCF MarginFCF / Revenue
26.1%
Capex IntensityCapex / Revenue
4.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-42.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PIII
PIII
TE
TE
Q4 25
$-25.7M
Q3 25
$-15.4M
$63.9M
Q2 25
$-16.6M
$33.4M
Q1 25
$-33.5M
$-44.8M
Q4 24
$-57.2M
Q3 24
$-22.6M
$-28.4M
Q2 24
$-10.2M
$-28.0M
Q1 24
$-20.0M
$-16.2M
Free Cash Flow
PIII
PIII
TE
TE
Q4 25
Q3 25
$55.0M
Q2 25
$10.6M
Q1 25
$-74.0M
Q4 24
Q3 24
$-34.0M
Q2 24
$-35.6M
Q1 24
$-37.7M
FCF Margin
PIII
PIII
TE
TE
Q4 25
Q3 25
26.1%
Q2 25
8.0%
Q1 25
-138.4%
Q4 24
Q3 24
Q2 24
Q1 24
Capex Intensity
PIII
PIII
TE
TE
Q4 25
Q3 25
4.2%
Q2 25
17.2%
Q1 25
54.5%
Q4 24
0.0%
Q3 24
0.0%
Q2 24
0.0%
Q1 24
0.0%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PIII
PIII

Capitated Revenue$366.2M95%
Health Care Patient Service$18.6M5%
Health Care Care Coordination Management Fees$2.7M1%

TE
TE

Related Party$120.1M57%
Nonrelated Party$90.4M43%

Related Comparisons